• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊班膦酸盐通过表观遗传机制增加肿瘤细胞中促凋亡基因 FAS 的表达。

Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells.

机构信息

Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Center Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.

出版信息

Biochem Pharmacol. 2013 Jan 15;85(2):173-85. doi: 10.1016/j.bcp.2012.10.016. Epub 2012 Oct 24.

DOI:10.1016/j.bcp.2012.10.016
PMID:23103563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3557391/
Abstract

There is growing evidence that aminobisphosphonates like ibandronate show anticancer activity by an unknown mechanism. Biochemically, they prevent posttranslational isoprenylation of small GTPases, thus inhibiting their activity. In tumor cells, activated RAS-GTPase, the founding member of the gene family, down-regulates the expression of the pro-apoptotic gene FAS via epigenetic DNA-methylation by DNMT1. We compared ibandronate treatment in neoplastic human U-2 osteosarcoma and in mouse CCL-51 breast cancer cells as well as in the immortalized non-neoplastic MC3T3-E1 osteoblastic cells. Ibandronate attenuated cell proliferation in all cell lines tested. In the neoplastic cells we found up-regulation of caspases suggesting apoptosis. Further we found stimulation of FAS-expression as a result of epigenetic DNA demethylation that was due to down-regulation of DNMT1, which was rescued by re-isoprenylation by both geranylgeranyl-pyrophosphate and farnesylpyrophosphate. In contrast, ibandronate did not affect FAS and DNMT1 expression in MC3T3-E1 non-neoplastic cells. Data suggest that bisphosphonates via modulation of the activity of small-GTPases induce apoptosis in neoplastic cells by DNA-CpG-demethylation and stimulation of FAS-expression. In conclusion the shown epigenetic mechanism underlying the anti-neoplastic activity of farnesyl-transferase-inhibition, also explains the clinical success of other drugs, which target this pathway.

摘要

越来越多的证据表明,依班膦酸盐等氨基双膦酸盐通过未知机制显示出抗癌活性。从生化角度讲,它们可以阻止小 GTP 酶的翻译后异戊烯化,从而抑制其活性。在肿瘤细胞中,作为基因家族的创始成员,激活的 RAS-GTP 酶通过 DNMT1 介导的 DNA 甲基化来下调促凋亡基因 FAS 的表达。我们比较了依班膦酸盐在人 U-2 骨肉瘤和鼠 CCL-51 乳腺癌细胞以及永生化非肿瘤性 MC3T3-E1 成骨细胞中的治疗作用。依班膦酸盐可减弱所有测试细胞系的细胞增殖。在肿瘤细胞中,我们发现 caspase 的上调提示细胞凋亡。此外,我们发现 FAS 表达的刺激是由于 DNA 去甲基化的表观遗传作用所致,这是由于 DNMT1 的下调所致,而这可以通过 geranylgeranyl-pyrophosphate 和 farnesylpyrophosphate 的异戊烯化来挽救。相比之下,依班膦酸盐对非肿瘤性 MC3T3-E1 细胞中的 FAS 和 DNMT1 表达没有影响。数据表明,双膦酸盐通过调节小 GTP 酶的活性,通过 DNA-CpG 去甲基化和刺激 FAS 表达来诱导肿瘤细胞凋亡。总之,所显示的表观遗传机制是法尼基转移酶抑制的抗肿瘤活性的基础,也解释了其他靶向该途径的药物的临床成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/f9f49f54b03a/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/854be54cdf5f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/7aaec4d5350c/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/719cada4d03b/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/b74c630cc97c/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/8869ca2f0006/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/ca5d01f209c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/092db84b3c54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/b6cf15101d3d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/77be810068ba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/750a5b4dabf3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/0485d05ab3c7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/f9f49f54b03a/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/854be54cdf5f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/7aaec4d5350c/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/719cada4d03b/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/b74c630cc97c/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/8869ca2f0006/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/ca5d01f209c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/092db84b3c54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/b6cf15101d3d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/77be810068ba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/750a5b4dabf3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/0485d05ab3c7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b82/3557391/f9f49f54b03a/gr8.jpg

相似文献

1
Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells.伊班膦酸盐通过表观遗传机制增加肿瘤细胞中促凋亡基因 FAS 的表达。
Biochem Pharmacol. 2013 Jan 15;85(2):173-85. doi: 10.1016/j.bcp.2012.10.016. Epub 2012 Oct 24.
2
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.甲羟戊酸途径的抑制影响癌细胞中的表观遗传调控。
Cancer Genet. 2015 May;208(5):241-52. doi: 10.1016/j.cancergen.2015.03.008. Epub 2015 Mar 18.
3
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.5-氮杂胞苷和地西他滨对肿瘤性肥大细胞发挥促凋亡作用:FAS 去甲基化和 FAS 再表达的作用,以及与 Fas 配体的协同作用。
Blood. 2012 May 3;119(18):4242-52. doi: 10.1182/blood-2011-09-382770. Epub 2012 Mar 21.
4
Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.ZBP-89对Bak的表观遗传上调抑制肝细胞癌的生长。
Biochim Biophys Acta. 2013 Dec;1833(12):2970-2979. doi: 10.1016/j.bbamcr.2013.08.001. Epub 2013 Aug 13.
5
Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.含氮双膦酸盐通过抑制 Ras 信号通路和 Bim 介导的内在凋亡途径激活诱导造血肿瘤细胞凋亡。
Biochem Pharmacol. 2013 Jan 15;85(2):163-72. doi: 10.1016/j.bcp.2012.10.009. Epub 2012 Oct 17.
6
Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.苦参碱通过上调 Bax 和 Fas/FasL 以及下调 Bcl-2 诱导人骨肉瘤细胞体外和体内的 caspase 依赖性细胞凋亡。
Cancer Chemother Pharmacol. 2012 Feb;69(2):317-31. doi: 10.1007/s00280-011-1699-4. Epub 2011 Jun 30.
7
Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.泽布勒林通过抑制ARHI的甲基化增强人骨肉瘤细胞的凋亡。
Cancer Sci. 2016 Dec;107(12):1851-1857. doi: 10.1111/cas.13088. Epub 2016 Dec 19.
8
DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.DNA甲基化而非H3K4三甲基化决定了miR - 152基因的表达状态,该基因通过DNMT1/CDH1环路抑制乳腺癌细胞的迁移。
Exp Cell Res. 2016 Aug 15;346(2):176-87. doi: 10.1016/j.yexcr.2016.07.023. Epub 2016 Jul 28.
9
Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.马汉宁通过下调前列腺癌细胞中的 DNMT1 和 DNMT3B 来恢复 RASSF1A 的表达。
Mol Cancer. 2013 Aug 30;12(1):99. doi: 10.1186/1476-4598-12-99.
10
Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation.同型半胱氨酸通过涉及 IL-6、Fli1 和表观遗传 DNA 甲基化抑制胶原蛋白交联酶赖氨酰氧化酶的表达。
J Biol Chem. 2011 Feb 18;286(7):5578-88. doi: 10.1074/jbc.M110.166181. Epub 2010 Dec 9.

引用本文的文献

1
Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines.他汀类药物和双膦酸盐使快速生长的癌细胞系发生饥饿。
Int J Mol Sci. 2017 Sep 15;18(9):1982. doi: 10.3390/ijms18091982.
2
Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.天然存在的异硫氰酸盐——萝卜硫素通过表观遗传调控对骨稳态进行合成代谢和抗吸收调节
J Biol Chem. 2016 Mar 25;291(13):6754-71. doi: 10.1074/jbc.M115.678235. Epub 2016 Jan 12.
3
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.

本文引用的文献

1
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.5-氮杂胞苷和地西他滨对肿瘤性肥大细胞发挥促凋亡作用:FAS 去甲基化和 FAS 再表达的作用,以及与 Fas 配体的协同作用。
Blood. 2012 May 3;119(18):4242-52. doi: 10.1182/blood-2011-09-382770. Epub 2012 Mar 21.
2
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.口服双膦酸盐治疗绝经后妇女降低结直肠癌发病率和死亡率-丹麦全国注册队列研究。
Osteoporos Int. 2012 Nov;23(11):2693-701. doi: 10.1007/s00198-012-1902-4. Epub 2012 Mar 6.
3
抗吸收治疗与骨质疏松相关髋部骨折的死亡率及再骨折风险:一项全国性研究
Osteoporos Int. 2016 Jan;27(1):387-96. doi: 10.1007/s00198-015-3415-4. Epub 2015 Nov 17.
4
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.骨肉瘤的遗传学与表观遗传学:新兴生物学与候选疗法
Crit Rev Oncog. 2015;20(3-4):173-97. doi: 10.1615/critrevoncog.2015013713.
5
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.甲羟戊酸途径的抑制影响癌细胞中的表观遗传调控。
Cancer Genet. 2015 May;208(5):241-52. doi: 10.1016/j.cancergen.2015.03.008. Epub 2015 Mar 18.
6
ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.NADPH氧化酶5介导的ROS信号传导调节前列腺癌细胞的增殖和存活。
Mol Carcinog. 2016 Jan;55(1):27-39. doi: 10.1002/mc.22255. Epub 2015 Jan 5.
7
The effect of alendronate on proteome of hepatocellular carcinoma cell lines.阿仑膦酸盐对肝癌细胞系蛋白质组的影响。
Int J Proteomics. 2014;2014:532953. doi: 10.1155/2014/532953. Epub 2014 Feb 6.
8
Epigenetic alterations in osteosarcoma: promising targets.骨肉瘤中的表观遗传改变:有前景的靶点。
Mol Biol Rep. 2014 May;41(5):3303-15. doi: 10.1007/s11033-014-3193-7. Epub 2014 Feb 6.
9
A new bisphosphonate derivative, CP, induces gastric cancer cell apoptosis via activation of the ERK1/2 signaling pathway.一种新的双膦酸盐衍生物 CP 通过激活 ERK1/2 信号通路诱导胃癌细胞凋亡。
Acta Pharmacol Sin. 2013 Dec;34(12):1535-44. doi: 10.1038/aps.2013.103. Epub 2013 Nov 18.
Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells.
人法尼基焦磷酸合酶活性位点抑制剂的设计与合成:对多发性骨髓瘤细胞的细胞凋亡和 ERK 磷酸化的抑制作用。
J Med Chem. 2012 Apr 12;55(7):3201-15. doi: 10.1021/jm201657x. Epub 2012 Mar 19.
4
Antiresorptive therapies in oncology and their effects on cancer progression.肿瘤学中的抗再吸收疗法及其对癌症进展的影响。
Cancer Treat Rev. 2012 Oct;38(6):776-86. doi: 10.1016/j.ctrv.2012.02.002. Epub 2012 Feb 26.
5
Potential therapeutic effects of oral bisphosphonates on the intestine.口服双膦酸盐对肠道的潜在治疗作用。
Ann N Y Acad Sci. 2011 Dec;1240:E19-25. doi: 10.1111/j.1749-6632.2011.06372.x.
6
Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study.静脉用氯膦酸盐对高危前列腺癌患者骨转移延迟的辅助作用:一项前瞻性研究。
Cancer Res Treat. 2011 Dec;43(4):231-5. doi: 10.4143/crt.2011.43.4.231. Epub 2011 Dec 27.
7
Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate.治疗前列腺癌骨转移:一种新型双膦酸盐的疗效。
Anticancer Res. 2011 Dec;31(12):4141-5.
8
Regulating the regulator: post-translational modification of RAS.调节蛋白的调节作用:RAS 的翻译后修饰。
Nat Rev Mol Cell Biol. 2011 Dec 22;13(1):39-51. doi: 10.1038/nrm3255.
9
Exposure to oral bisphosphonates and risk of cancer.口服双膦酸盐暴露与癌症风险。
Int J Cancer. 2012 Sep 1;131(5):E717-25. doi: 10.1002/ijc.27389. Epub 2012 Jan 11.
10
Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.Rac 信号在成骨细胞中对于正常骨发育是必需的,但对于造血发育是可有可无的。
Blood. 2012 Jan 19;119(3):736-44. doi: 10.1182/blood-2011-07-368753. Epub 2011 Nov 28.